Related Experiment Video
Updated: Jan 29, 2026

Invasive Behavior of Human Breast Cancer Cells in Embryonic Zebrafish
Published on: April 25, 2017
AKT-dependent sugar addiction by benzyl isothiocyanate in breast cancer cells
Ruchi Roy1, Eun-Ryeong Hahm1, Alexander G White2
1Department of Pharmacology & Chemical Biology, Pittsburgh, Pennsylvania.
Abstract:
The overall promise of breast cancer chemoprevention is exemplified by clinical success of selective estrogen receptor modulators and aromatase inhibitors. Despite clinical efficacy, these interventions have limitations, including rare but serious side effects and lack of activity against estrogen receptor-negative breast cancers. We have shown previously that dietary administration of benzyl isothiocyanate (BITC), which occurs naturally as a thioglucoside conjugate in edible cruciferous vegetables, inhibits development of estrogen receptor-negative breast cancer in mouse mammary tumor virus-neu (MMTV-neu) transgenic mice. This study demonstrates AKT-mediated sugar addiction in breast cancer chemoprevention by BITC. BITC-treated MMTV-neu mice exhibited increased 2-deoxy-2-(18 F)-fluoro-D-glucose (18 F-FDG) uptake in mammary tumors in vivo in comparison with mice fed basal diet. Cellular studies using MDA-MB-231 and SUM159 human breast cancer cell lines revealed BITC-mediated induction and punctate localization of glucose transporter GLUT-1, which was accompanied by an increase in intracellular pyruvate levels. BITC treatment resulted in increased S473 phosphorylation (activation) of AKT in cells in vitro as well as in mammary tumors of MMTV-neu mice in vivo. Increased glucose uptake, punctate pattern of GLUT-1 localization, and intracellular pyruvate levels resulting from BITC exposure were significantly attenuated in the presence of a pharmacological inhibitor of AKT (MK-2206). Inhibition of AKT augmented BITC-mediated inhibition of cell migration and colony formation. BITC-induced apoptotic cell death was also increased by pharmacological inhibition of AKT. These results indicate increased glucose uptake/metabolism by BITC treatment in breast cancer cells suggesting that breast cancer chemoprevention by BITC may be augmented by pharmacological inhibition of AKT.
Insights
Benzyl isothiocyanate (BITC) enhances glucose uptake in breast cancer cells via AKT activation. Combining BITC with AKT inhibitors may improve chemoprevention strategies for estrogen receptor-negative breast cancer.
Area of Science:
- Oncology
- Biochemistry
- Molecular Biology
Background:
- Selective estrogen receptor modulators and aromatase inhibitors show promise in breast cancer chemoprevention but have limitations.
- Estrogen receptor-negative breast cancers remain a challenge for current therapies.
- Benzyl isothiocyanate (BITC), found in cruciferous vegetables, has previously shown efficacy in inhibiting estrogen receptor-negative breast cancer development.
Purpose of the Study:
- To investigate the mechanism of breast cancer chemoprevention by BITC, focusing on AKT-mediated sugar addiction.
- To explore the potential synergistic effects of BITC and AKT inhibition in breast cancer treatment.
Main Methods:
- Utilized MMTV-neu transgenic mice and human breast cancer cell lines (MDA-MB-231, SUM159).
- Assessed 2-deoxy-2-(18F)-fluoro-D-glucose (18F-FDG) uptake using in vivo imaging.
- Analyzed glucose transporter GLUT-1 expression and localization, intracellular pyruvate levels, and AKT phosphorylation (S473).
- Employed pharmacological AKT inhibitor (MK-2206) to evaluate synergistic effects on cell migration, colony formation, and apoptosis.
Main Results:
- BITC treatment increased 18F-FDG uptake in mammary tumors and induced GLUT-1 expression and punctate localization in cancer cells.
- BITC elevated intracellular pyruvate levels and activated AKT (S473 phosphorylation) in vitro and in vivo.
- Pharmacological inhibition of AKT attenuated BITC-induced glucose uptake and pyruvate increase.
- AKT inhibition potentiated BITC's effects on inhibiting cell migration and colony formation, and enhanced BITC-induced apoptosis.
Conclusions:
- BITC treatment increases glucose uptake and metabolism in breast cancer cells through an AKT-mediated pathway.
- Combined therapy of BITC and AKT inhibition demonstrates augmented anti-cancer effects, suggesting a potential novel chemoprevention strategy.
- This study elucidates a mechanism for BITC's chemopreventive action and highlights the therapeutic potential of targeting AKT signaling in breast cancer.
Related Concept Videos
Phloem and Sugar Transport
Reactions at the Benzylic Position: Halogenation
Sugars as Energy Storage Molecules
Drug Abuse and Addiction: Pharmacological Phenomena
PI3K/mTOR/AKT Signaling Pathway
Reactions at the Benzylic Position: Oxidation and Reduction

